| argenx Switzerland SA - Vyvgart 1000 mg/ 5 ml, solution injectable en seringue préremplie | | 70518 | | 01 | | Vyvgart 1000 mg/ 5 ml | | solution injectable en seringue préremplie | | L04AL01 | | Efgartigimod Alfa | | 12.05.2026 | | |
| | Composition | | efgartigimodum alfa 1000 mg, hyaluronidasum humanum ADNr, arginini hydrochloridum, histidinum, histidini hydrochloridum monohydricum, dl-methioninum, natrii chloridum corresp. natrium 8.1 mg, saccharum, polysorbatum 80, aqua ad iniectabile q.s. ad solutionem pro 5 ml. | | Packungsbestandteile | | solution injectable en seringue préremplie | | | | | | Active Agent | Dose |
|---|
| Efgartigimodum Alfa | 1000mg / 5ml |
| | | | Inactive agents |
|---|
| Arginine Hydrochloride | | DL-Methionine | | Histidin Hydrochloride Monohydrate | | Histidine | | Hyaluronidasum Humanum Adnr | | Sodium Chloride | | Polysorbatum 80 | | Saccharum |
|
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | | | | A | | No | | 002 | 4 | | | A | | No |
|
|
